PathAI develops AI software and digital pathology systems used in diagnostic workflows, clinical research, and drug development.
PathAI has raised $100.0M in total funding. The most recent round was Debt Financing. The last funding was announced in January 2022.
PathAI's investors include General Atlantic, General Catalyst, 8VC, Tiger Global Management, Pillar VC.
PathAI is headquartered in Boston, United States.
PathAI develops AI software and digital pathology systems used in diagnostic workflows, clinical research, and drug development.
PathAI is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PathAI — Funding & Investors." VCBacked, January 1, 2022, https://www.vcbacked.co/company/pathai. Accessed August 13, 2026.
VCBacked. (2022). PathAI — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/pathai
{{cite web |title=PathAI — Funding & Investors |url=https://www.vcbacked.co/company/pathai |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated